Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 14, 2015
[Recognition mechanism of hepatitis C viral infection]Hiromichi Dansako, Nobuyuki Kato
The FEBS Journal|July 27, 2007
Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytesHiromichi Dansako, Masanori Ikeda, Nobuyuki Kato
Bio-Protocol|October 31, 2017
Co-immunoprecipitation of Flag-TLR3 or Myc-MSR1 with HCV RNADaisuke Yamane, Hiromichi Dansako, Stanley M Lemon
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 27, 2021
Extracellular vesicles activate ATM-Chk2 signaling pathway through the intercellular transfer of mitochondrial DNA in HBV-infected human hepatocytesHiromichi Dansako, Youki Ueda, Shinya Satoh, et al.
Biochemical and Biophysical Research Communications|September 6, 2005
Hepatitis C virus proteins exhibit conflicting effects on the interferon system in human hepatocyte cellsHiromichi Dansako, Kazuhito Naka, Masanori Ikeda, et al.
Cancer Research|February 20, 2004
Promotion of microsatellite instability by hepatitis C virus core protein in human non-neoplastic hepatocyte cellsAtsushi Naganuma, Hiromichi Dansako, Takashi Nakamura, et al.
Virology|December 6, 2005
Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomesKazuhito Naka, Hiromichi Dansako, Naoya Kobayashi, et al.
Archives of Virology|April 9, 2009
Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseasesHiromichi Dansako, Masanori Ikeda, Yasuo Ariumi, et al.
FEBS Letters|April 1, 2009
Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alphaMasanori Ikeda, Kyoko Mori, Yasuo Ariumi, et al.
Biochemical and Biophysical Research Communications|September 14, 2018
Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune responseHirotaka Imai, Hiromichi Dansako, Youki Ueda, et al.
Pageof 8